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Previously we have shown that Lelystad virus (LV) contains five structural proteins, a nucleocapsid protein N, an integral
membrane protein M, and three glycoproteins GP3 , GP4 , and GP5 . In this study we identified a sixth structural protein of
Lelystad virus. The protein has an apparent molecular weight of 29 to 30 kDa, was recognized by an ORF2-specific antipeptide
serum in Western immunoblotting using sucrose gradient purified LV virions, and was shown to be N-glycosylated. It was
therefore designated GP2 . The GP2 protein was also immunoprecipitated by ORF2-specific antipeptide serum from lysates
and extracellular virus of CL2621 cells infected with LV. A fraction of the GP2 protein present in these lysates contained
an intrachain disulfide bond. Endoglycosidase H treatment of immunoprecipitates indicated that the endoglycosidase H-
sensitive N-glycans of the GP2 protein become endoglycosidase H-resistant during passage through the Golgi compartment
in cells infected with LV. In contrast, the N-glycans of the GP2 protein expressed individually in a recombinant Semliki Forest
virus remained endoglycosidase H-sensitive, indicating that the GP2 protein was retained in the endoplasmic reticulum. LV
is the first arterivirus which has been demonstrated to contain six virion-associated proteins, one nucleocapsid protein,
one integral membrane protein, and four glycoproteins. q 1996 Academic Press, Inc.
INTRODUCTION et al., 1995). Similar proteins have also been detected in
lysates of cells infected with a North American isolate,
Lelystad virus (LV) is the European prototype of por- VR2332, which is antigenically different from LV (Nelson
cine reproductive and respiratory syndrome virus and et al., 1993). Recently we isolated monoclonal antibodies
causes respiratory problems in pigs and abortions in (MAbs) directed against LV and used them to demon-
sows (Wensvoort et al., 1991). LV belongs to a family of strate that GP3 , which is a 45- to 50-kDa protein that is
enveloped positive-strand RNA viruses called arterivir- N-glycosylated and encoded by ORF3, and GP4 , which
uses. Other viruses in this family are equine arteritis virus is a 31- to 35-kDa protein that is N-glycosylated and
(EAV), lactate dehydrogenase-elevating virus (LDV), and encoded by ORF4, are also structural glycoproteins (van
simian hemorrhagic fever virus (Meulenberg et al., 1993; Nieuwstadt et al., 1996). Because the MAbs directed
Plagemann and Moennig, 1993). Arteriviruses resemble against GP4 were neutralizing, at least part of this protein
togaviruses in their physicochemical properties and vi- is probably exposed at the surface of the virion.
rion morphology, but resemble coronaviruses in their ge- In this report we describe the identification and char-
nome organization and replication strategy. acterization of a sixth structural protein, designated GP2 .
LV contains a positive-strand RNA genome of 15.1 kb, By Western immunoblotting and immunoprecipitation we
and during replication a nested set of six subgenomic demonstrate that GP2 is a 29- to 30-kDa N-glycosylated
RNAs is synthesized (Meulenberg et al., 1993; Conzel- protein encoded by ORF2 and is incorporated in virus
mann et al., 1993). The genes located at the 5* end of particles. The folding and intracellular transport of the
the viral genome (ORFs 1a and 1b) occupy approximately GP2 protein are analyzed.
80% of the viral genome and encode the RNA-dependent
RNA polymerase. Six smaller ORFs (ORFs 2 to 7) are
MATERIALS AND METHODS
located at the 3* end of the viral genome. ORFs 3 to 7
encode structural proteins of LV. The 15-kDa nucleocap- Cells and viruses
sid protein (N) encoded by ORF7, the 18-kDa integral
The European prototype Ter Huurne strain of LV wasmembrane protein (M) encoded by ORF6, and the major
isolated in 1991 (Wensvoort et al., 1991). To prepare LV25-kDa envelope glycoprotein (GP5) were identified in
virions, we grew LV in CL2621 cells. The virus was con-virions with gene-specific antipeptide sera (Meulenberg
centrated and purified on sucrose gradients as described
earlier (van Nieuwstadt et al., 1996).
BHK-21 cells were maintained in Dulbecco’s minimal1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 31-320238668. E-mail: J.J.M.Meulenberg@id.dlo.nl. essential medium supplemented with 5% fetal bovine se-
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rum and antibiotics. For transfection experiments, BHK- medium containing 5 mM nonradioactive L-methionine
and 10% fetal bovine serum, and chased in the same21 cells were grown in Glasgow minimal essential me-
dium (GIBCO-BRL/Life Technologies Ltd.), according to medium for various intervals. Lysates were prepared
from these cells and were used in immunoprecipitation.the method of Liljestro¨m and Garoff (1993).
In order to immunoprecipitate GP2 expressed by SFV-
Expression of GP2 in recombinant Semliki ORF2, we first activated SFV-ORF2 particles by cleaving
Forest virus them with chymotrypsin according to the method of Ber-
glund et al. (1993). CL2621 or BHK-21 cells were thenORF2 was excised from plasmid pABV210, by digest-
inoculated with the activated SFV-ORF2 stock at a multi-ing with SmaI and SphI (partially). This plasmid was
plicity of infection of 5. The cells were labeled and lysedshown earlier to express the GP2 protein properly in in
as described for the CL2621 cells infected with LV.vitro transcription and translation experiments (Meulen-
For the preparation of radiolabeled virus, CL2621 cellsberg et al., 1995). The ORF2 fragment was treated with
were infected with LV at a multiplicity of infection of 1,Klenow polymerase (Pharmacia) to create blunt ends and
and after 8 hr they were labeled for 24 hr with 60 mCi L-was ligated in the SmaI site of expression vector pSFV1
[35S]methionine/ml Eagle’s basal medium containing 0.5Liljestro¨m and Garoff (1993), which was dephosphory-
mM nonradioactive L-methionine and 1% fetal bovine se-lated with calf intestinal alkaline phosphatase (Phar-
rum. The culture supernatant was harvested, layered onmacia). A plasmid containing ORF2 of LV (pABV262) in
a sucrose cushion of 0.5 M sucrose in TNE, and centri-the correct orientation was used to obtain recombinant
fuged for 6 hr at 26,000 rpm in a SW40 rotor (Beckmann).Semliki Forest viruses expressing the GP2 protein. The
The pellet of radiolabeled virus was resuspended in TNEplasmids pABV262 and pSFV-Helper2 were linearized
and the LV virions were disrupted by adding an equalwith SpeI, and RNA was transcribed in vitro as described
volume of PBS-TDS.by Liljestro¨m and Garoff (1993). These RNAs were cotrans-
fected into BHK-21 cells by electroporation (Liljestro¨m
Immunoprecipitation, endoglycosidase treatment, andand Garoff, 1993) and the resulting recombinant virus
gel electrophoresis(SFV-ORF2) was tested for GP2 expression by immuno-
precipitation.
Cell lysates and extracellular virus of CL2621 cells
infected with LV or SFV-ORF2 were diluted in PBS-TDSWestern blot analysis
and immunoprecipitated with antipeptide sera 687, 689,
Western blot analysis of purified virions of LV was 689-p, or the N-specific MAb 122.17. Antipeptide serum
performed as described previously (van Nieuwstadt et 687 is directed against amino acids 35 to 50 (CLGSPS-
al., 1996). The nitrocellulose strips were incubated with QDGYWSFFSE) in the GP2 protein. This peptide serum
MAbs 126.2 (GP3) and 130.7 (GP4), GP5-specific antipep- was obtained from a rabbit immunized twice with 1 mg
tide serum 704, GP2-specific antipeptide serum 689, the peptide conjugated to keyhole limpet hemocyanin, as
corresponding preserum 689-p, and porcine anti-LV se- described previously (Meulenberg et al., 1995). LV virions
rum 21 (Meulenberg et al., 1995; van Nieuwstadt et al., prepared as described above were diluted in PBS-TDS
1996). The hybridoma cell culture medium was used un- and were immunoprecipitated in a similar manner as
diluted, but the antipeptide sera 704 and 689, the corre- were the lysates, according to the method of Hulst et al.
sponding preserum 689-p, and serum 21 were diluted (1993). When disulfide bonds were studied, iodoacet-
1:25, 1:5, 1:5, and 1:50, respectively. amide (IAA, 50 mM) or N-ethylmaleimide (NEM, 20 mM)
was added to the PBS-TDS to block free sulfhydryl
Metabolic labeling of cells and virus
groups to prevent the formation of disulfide bridges dur-
ing or after lysis of cells or virus. Immunoprecipitates ofConfluent monolayers of CL2621 cells were infected
with LV at a multiplicity of infection of 1, and after 18 LV proteins were either directly resuspended in Laemmli
sample buffer (Laemmli, 1970) with (reducing conditions)hr cells were labeled with 90 mCi L-[35S]methionine/ml
methionine-free Eagle’s basal medium. The cells were or without (nonreducing conditions) 10% (v/v) 2-mercap-
toethanol, or they were first treated with endoglycosi-labeled for 4 hr, after which lysates were prepared in
PBS-TDS (1% Triton X-100, 0.5% sodium deoxycholate, dases before being resuspended. In the latter case, the
samples were resuspended in the appropriate endogly-0.1% sodium dodecyl sulfate, and 1 mM phenylmethylsul-
fonyl fluoride in PBS), according to Meulenberg et al. cosidase buffer and treated with peptide N-glycosidase
F (PNGaseF; Boehringer Mannheim) or endo-b-N-acetyl-(1995). For pulse–chase experiments, CL2621 cells were
infected with LV at a multiplicity of infection of 1, and D-glycosaminidase H (EndoH; Boehringer Mannheim) as
described previously (Meulenberg et al., 1995). Samplesafter 18 hr cells were starved for 45 min in methionine-
free Eagle’s basal medium. The cells were pulse-labeled were resuspended in Laemmli sample buffer and ana-
lyzed by sodium dodecyl sulfate–polyacrylamide gelwith 600 mCi L-[35S]methionine/ml methionine-free Ea-
gle’s basal medium for 30 min, washed in Eagles basal electrophoresis (SDS–PAGE).
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Western blot analysis in previous experiments. In these
experiments 1 to 2 mg protein of the purified LV preparation
was used per nitrocellulose strip, and the peptide serum
was diluted 1:50. The improvement of virus growth and
purification methods enabled us to repeat this experiment
with 10 mg virion protein per nitrocellulose strip. This strip
was stained with serum 689 diluted 1:5, and a protein with
an apparent molecular weight of 29 to 30 kDa was ob-
served. This protein was barely distinguishable in size from
the GP4 protein (Fig. 1). The 29- to 30-kDa protein was
also stained by serum 690, although the staining was less
intense (data not shown), but it was not stained by the
corresponding preserum 689-p (Fig. 1). Hence, these re-
sults indicated that the 29- to 30-kDa protein encoded by
ORF2 is a minor structural protein of LV.
N-glycosylation of the gene product of ORF2 of LV
The processing of the gene product of ORF2 was stud-
ied by immunoprecipitation and endoglycosidase treat-
ment. In previous experiments we were unable to immu-
noprecipitate a specific protein with serum 689 from ly-
sates of CL2621 cells that were infected with LV at a
multiplicity of infection of 0.1 and that were labeled be-
tween 24 and 40 hr after infection. However, a specific
28-kDa protein and a faint, more diffuse species of 29
to 30 kDa could be immunoprecipitated from lysates of
FIG. 1. Western immunoblot analysis of virion proteins of LV. The CL2621 cells infected at a multiplicity of infection of 1
proteins were separated by SDS–PAGE on a gel containing 12.5% and labeled between 18 and 22 hr after infection (Fig.
acrylamide under reducing conditions and transferred to nitrocellulose. 2a). These proteins were not immunoprecipitated by the
Nitrocellulose strips, containing 10 mg of the purified virion proteins,
corresponding preserum 689-p from lysates of LV-in-were stained with MAb 126.2, MAb 130.7, antipeptide sera 704 and
fected CL2621 cells. Some background bands were ob-689, the corresponding preserum 689-p, and porcine anti-LV serum 21.
The position of the LV proteins GP2 , GP3 , GP4 , GP5 , M, and N are served at about 46 kDa, which appeared to be caused
indicated with arrows. Numbers on the left show the sizes and position by nonspecific reactions, since they were also recog-
of the molecular weight markers. nized by preserum 689-p. The 28-kDa gene product of
ORF2 recognized by serum 689 in the lysates was
smaller than the gene product recognized in extracellularRESULTS
virus of CL2621 cells infected with LV (29 to 30 kDa; Fig.
Identification of the ORF2 gene product
2a). The 15-kDa N protein was nonspecifically immuno-
in virions of LV
precipitated from the extracellular virus by serum 689
and 689-p. Nonspecific immunoprecipitation of the N pro-To further examine structural proteins of LV, virions were
purified and analyzed by Western blots. As shown earlier, tein of LV was observed earlier, if N was present in large
amounts in the sample, and it seems to be a commonMAb 126.2 recognized the 45- to 50-kDa GP3 protein, MAb
130.7 recognized the 31- to 35-kDa GP4 protein, antipeptide phenomenon, also reported for the EAV N protein (Deregt
et al., 1994). We do not understand why fewer N proteinsserum 704 recognized the 25-kDa GP5 protein, whereas
porcine anti-LV serum 21 recognized all three of these were coprecipitated from the lysates. Perhaps the ratio
of the N protein and the ORF2 gene product is higher inglycoproteins as well as the 18-kDa M protein and the 15-
kDa N protein (Fig. 1; Meulenberg et al., 1995; van Nieuw- the extracellular virus than in the cell lysate of CL2621
cells infected with LV. This was also demonstrated forstadt et al., 1996). The M and N proteins migrated as a
smear because of the large amount of viral protein loaded the N protein and the gene product of ORF2 (Gs) of EAV
(de Vries et al., 1992).in the gel. Although antipeptide sera 689 and 690, which
were obtained from two rabbits immunized with the same The gene product of ORF2, which was immunoprecipi-
tated from the lysates and extracellular virus of CL2621peptide derived from the amino acid sequence of ORF2
(Meulenberg et al., 1995), recognized in vitro translation cells infected with LV, was treated with PNGaseF and
EndoH and analyzed by SDS–PAGE. The size of this 28-products of ORF2 in the immunoprecipitation assay, we
were unable to identify specific proteins with these sera in kDa gene product was decreased to 24 kDa by PNGase
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FIG. 2. Immunoprecipitation of GP2 from lysates and extracellular virus of CL2621 cells infected with LV. For the preparation of radiolabeled cell
lysates, CL2621 cells were infected with LV, and after 18 hr they were labeled for 4 hr with L-[35S]methionine. For the preparation of radiolabeled
virus, CL2621 cells were labeled with L-[35S]methionine between 8 and 32 hr after infection with LV. (a) Cell lysates (CL) and extracellular virus (EV)
of CL2621 cells infected with LV were immunoprecipitated with ORF2-specific antipeptide serum 689 and the corresponding preserum 689-p. (b)
Immunoprecipitation of GP2 with serum 689 from cell lysates (CL) and extracellular virus (EV) of CL2621 cells infected with LV. The immunoprecipitated
GP2 protein was either untreated (U), PNGaseF treated (F), or EndoH treated (H). The samples were analyzed in a SDS–12.5% polyacrylamide gel
under reducing conditions. The position of the molecular weight markers is indicated on the left.
F (Fig. 2b). The size of the 28-kDa protein was also re- The GP2 protein was also immunoprecipitated from
CL2621 cells infected with SFV-ORF2. Although SFV-duced to 24 kDa, but the diffuse smear of 29 to 30 kDa
was EndoH resistant. The size of the 29- to 30-kDa pro- ORF2 infected the CL2621 cells less efficiently than the
BHK-21 cells, sufficient amounts of GP2 could be immu-tein immunoprecipitated from extracellular virus was also
decreased to 24 kDa after treatment with PNGaseF, but noprecipitated to compare the processing of this recom-
binant GP2 protein with the processing of GP2 in CL2621did not change after treatment with EndoH (Fig. 2b).
Therefore we concluded that the protein encoded by cells infected with LV in a pulse–chase experiment. The
apparent molecular weight of the GP2 protein expressedORF2 is an N-glycosylated structural protein that ac-
quires complex type N-glycans. This protein was desig- by SFV-ORF2 was similar to that of GP2 expressed in
CL2621 cells infected with LV (Fig. 4 compared to Fig. 3).nated GP2 . The difference in size (approximately 6 kDa)
between the glycosylated and the unglycosylated forms However, unlike the latter, it remained EndoH-sensitive
throughout the chase (Fig. 4). In addition to the 24-kDaof the protein suggests that both of the putative N-glyco-
sylation sites identified in the amino acid sequence of unglycosylated form of GP2 , observed earlier (Fig. 3), a
fainter band of approximately 26 kDa was observed inORF2 are used in vivo.
A pulse–chase experiment was performed to examine all samples digested with EndoH. This 26-kDa band most
likely results from incomplete EndoH digestion. The re-the acquisition of EndoH-resistant N-glycans by the GP2
protein in time. The apparent molecular weight of the 28- sults suggested that the GP2 protein expressed individu-
ally by SFV-ORF2 is retained in the endoplasmic reticu-kDa GP2 protein that was immunoprecipitated from cells
infected with LV after the pulse increased during the lum (ER) and that it must interact with other viral proteins
to be transported through the Golgi complex. The GP2chase, resulting in a more diffuse protein of approxi-
mately 29 to 30 kDa (Fig. 3). Whereas the N-glycans of protein expressed by SFV-ORF2 was also recognized by
serum 21 in immunoprecipitation (data not shown). Thisthe GP2 protein remained PNGase sensitive throughout
the chase, the GP2 protein faded and acquired EndoH- further supported our finding that GP2 is a minor struc-
tural protein.resistant N-glycans. Another partially EndoH-resistant
28-kDa form of the GP2 protein became visible during
Disulfide bonds in GP2the chase. This might be an intermediate containing one
EndoH-resistant and one EndoH-sensitive N-glycan or The mobility of the GP2 protein immunoprecipitated
from cell lysates and extracellular medium was also stud-might be due to incomplete digestion.
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FIG. 3. Acquisition of EndoH resistance by the GP2 protein. CL2621 cells were infected with LV, and 18 hr after infection they were pulse-labeled
for 30 min with L-[35S]methionine and chased in medium containing 5 mM nonradioactive methionine. The length of the chase is indicated in minutes
above the lanes. Lysates were prepared and immunoprecipitated with antipeptide serum 689. The immunoprecipitated proteins were treated with
PNGaseF (F) or EndoH (H) or were left untreated (U) before analysis by SDS–PAGE on a gel containing 12.5% acrylamide under reducing conditions.
The numbers on the left show the sizes of marker proteins in kDa.
ied under nonreducing conditions by leaving out the 2- tide serum 687, which is directed to a different site (Fig.
5). Hence, we conclude that the GP2 protein does notmercaptoethanol from the sample buffer. No difference in
form dimers by means of disulfide bridges. The N protein,migration of GP2 immunoprecipitated from extracellular
which was nonspecifically coprecipitated from extracel-virus was observed when GP2 was analyzed by SDS –
lular virus by sera 687 and 689 and which migrated atPAGE under nonreducing conditions compared to reduc-
15 kDa under reducing conditions, could not be detecteding conditions (Fig. 5). It may be that GP2 dimers are
under nonreducing conditions (Fig. 5), because disulfide-present in virions of LV but are not recognized by the
linked dimers of the N protein were present. These di-antipeptide serum 689, which could happen if the binding
site in the GP2 dimer is inaccessible to the antibodies
of the antipeptide serum. However, this seems unlikely,
because we also detected only monomeric GP2 proteins
after immunoprecipitation of extracellular virus with pep-
FIG. 4. Processing of GP2 expressed by SFV-ORF2. The CL2621 cells
were infected with SFV-ORF2, and 18 hr after infection they were pulse- FIG. 5. SDS–PAGE of GP2 under reducing and nonreducing condi-
tions. Lysates (CL) and extracellular virus (EV) of CL2621 cells infectedlabeled for 30 min with L-[35S]methionine and chased in medium con-
taining 5 mM nonradioactive methionine. The length of the chase is with LV and labeled with L-[35S]methionine were immunoprecipitated
with ORF2-specific antipeptide sera 687 and 689, and N-specific MAbindicated in minutes above the lanes. Lysates were prepared and im-
munoprecipitated with antipeptide serum 689. The immunoprecipitated 122.17. Immunoprecipitates were resuspended in Laemmli loading
buffer with (reducing, /2-ME) or without (nonreducing, 02-ME) 10% (v/proteins were treated with EndoH (H) or were left untreated (U) before
analysis by SDS–PAGE on a gel containing 12.5% acrylamide under v) 2-mercaptoethanol. Samples were analyzed by SDS–PAGE on a gel
containing 12.5% acrylamide. The numbers on the left show the sizesreducing conditions. The numbers on the left show the sizes of marker
proteins in kDa. of marker proteins in kDa.
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FIG. 6. Disulfide bonds detected in the GP2 protein in CL2621 cells infected with LV. The CL2621 cells were infected with LV, and 18 hr after
infection they were pulse-labeled for 30 min with L-[35S]methionine and chased in medium containing 5 mM nonradioactive methionine. The length
of the chase is indicated in minutes above the lanes. Cells were lysed in lysis buffer (PBS-TDS) containing 50 mM IAA and the lysates were
immunoprecipitated with serum 689. (a) The immunoprecipitated GP2 protein was analyzed by SDS–PAGE under reducing (/2-ME) and nonreducing
(02-ME) conditions. (b) The immunoprecipitated GP2 protein was treated with EndoH (H) or was left untreated (U) before analysis by SDS–PAGE
on a gel containing 12.5% acrylamide under nonreducing conditions. The numbers on the left show the sizes of marker proteins in kDa.
mers comigrated with the GP2 protein at 29 kDa, as was bonded structure since they migrated as a single band
of about 28 kDa under reducing conditions. The uppershown by immunoprecipitation of extracellular virus with
MAb 122.17, which is specific for N (Fig. 5). Although no band observed under nonreducing conditions comi-
grated with the single GP2 band detected under reducingslower migrating species were observed after immuno-
precipitation of GP2 from cell lysates of CL2621 cells conditions and therefore probably lacks intrachain disul-
fide bridges. The faster migrating form is expected toinfected with LV, a diffuse and slightly faster migrating
protein species was observed under nonreducing condi- contain one intramolecular disulfide bridge, because the
amino acid sequence of GP2 contains two luminal cys-tions (Fig. 5). Since the mobility of proteins in SDS–PAGE
increases as the protein acquires more compact confor- teine residues, provided that the signal sequence is
cleaved off between amino acids 29 and 30, accordingmations stabilized by disulfide bonds, we reasoned that
intramolecular disulfide bonds are formed in GP2 . There- to von Heijne’s rule (1986). Both species were sensitive
to EndoH directly after the pulse and were convertedfore we investigated the GP2 protein in another pulse–
chase experiment, in which we lysed the LV-infected during the chase to the same EndoH-resistant species,
observed in the pulse–chase experiment that lacked IAAcells in the presence of 50 mM iodoacetamine (IAA) or
20 mM N-ethylmaleimide (NEM). These alkylating agents in the lysis buffer (Fig. 6b compared to Fig. 3). The inten-
sity of the slower migrating, reduced form of GP2 de-block free sulfhydryl groups and thus prevent nonnative
disulfide bridges from forming during or after lysis of the creased somewhat faster during the chase than the
faster migrating disulfide-bonded form of GP2 . This find-cells. It has been shown that the resolution of multiple
differentially disulfide-bonded species of viral glycopro- ing suggested that the reduced form of GP2 is more trans-
port-competent than the disulfide-bonded form. The re-teins is improved when artifactual disulfide bond forma-
tion is inhibited through IAA and NEM (de Vries et al., duced form of GP2 is transported from the ER to the Golgi,
where its N-glycans are modified to complex type N-1995; Mulvey and Brown, 1994). The GP2 protein was
immunoprecipitated from CL2621 cells infected with LV, glycans, whereas the disulfide-bonded form is mainly
retained in the ER. The GP2 protein immunoprecipitatedpulse-labeled for 30 min with L-[
35S]methionine, and
lysed in the presence of IAA. Analysis of the sample from CL2621 cells infected with SFV-ORF2 also displayed
two forms under nonreducing conditions (data notunder nonreducing conditions revealed two distinct
forms of the protein (Fig. 6a). Identical results were ob- shown). These two forms remained equally EndoH-sensi-
tive during the chase. These findings further supportedtained when NEM was added to the lysis buffer (data not
shown). The two GP2 forms differed only in their disulfide- the assumption that the reduced form of GP2 is trans-
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ported from the ER through the Golgi as long as other secretory proteins typically occurs within the ER and is
an intrinsic part of the folding process, catalyzed by thestructural proteins of LV are present.
GP2 dimers were not identified in CL2621 cells infected enzyme protein disulfide isomerase (Bardwell and Beck-
with, 1993; Freedman, 1993). The correct folding andwith LV and lysed in the presence of IAA or NEM. Further-
more, when GP2 was immunoprecipitated from extracel- transport of viral membrane proteins in the ER is often
drastically impaired by in vivo reduction, as has beenlular virus after disruption in lysis buffer with or without
IAA or NEM, no dimeric or disulfide-bonded monomeric shown for the influenza HA protein (Braakman et al.,
1992), the vesicular stomatitis virus G protein (de Silva etforms were detected under nonreducing conditions (data
not shown). Hence, although an intramolecular disulfide al., 1993), and the mouse hepatitis coronavirus S protein
(Opstelten et al., 1993).bond may be formed during synthesis of GP2 , this disul-
fide bond was absent in the monomeric GP2 proteins In addition to the difference in dimerization, the rate
at which the GP2 proteins of LV and EAV are transporteddetected in virus particles.
through the Golgi compartment, as measured by the ac-
quirement of EndoH-resistant N-linked oligosaccharideDISCUSSION
chains, also appeared to differ. Pulse–chase experi-
ments indicated that most of the N-linked glycans of GP2In this study we identified and characterized a new
virus-specific protein in CL2621 cells infected with LV of LV were EndoH-resistant after a chase of 300 min,
whereas de Vries et al. (1995) found that the N-glycansand in LV virions. Our results demonstrate that the 29-
to 30-kDa GP2 protein encoded by ORF2 is a fourth virion- of Gs were already completely EndoH-resistant after a
chase of 120 min. However, this difference might beassociated glycoprotein, in addition to GP3 , GP4 , and
GP5 . The amino acid sequence of this protein shows caused by the fact that different cell types were used for
these experiments, namely CL2621 cells for LV and BHK-features reminiscent of typical class I integral membrane
glycoproteins. It contains an N-terminal signal sequence, 21 cells for EAV. The GP2 protein expressed individually
by SFV-ORF2 was retained in the ER, suggesting thata C-terminal hydrophobic sequence that may function as
a membrane anchor, and two putative N-glycosylation other structural proteins that are probably involved in
virus assembly are needed for proper transportation ofsites. We have shown that most likely both N-glycosyla-
tion sites are used in vivo and that the high mannose the GP2 protein through the Golgi. This was also ob-
served for the Gs protein of EAV by de Vries et al. (1995).oligosaccharides are converted very slowly to complex-
type oligosaccharides before or during incorporation of LV is the first arterivirus that has now been shown to
contain six structural proteins, four glycoproteins (desig-GP2 into virus particles. No disulfide-linked oligomers of
GP2 were detected in the lysates or extracellular virus of nated GP2 , GP3 , GP4 , and GP5), an integral membrane
protein (M), and a nucleocapsid protein (N). De Vries etCL2621 cells infected with LV. We cannot exclude the
possibility that multimeric forms of GP2 are nonetheless al. (1992) identified four structural proteins of EAV. These
were the glycoprotein Gl encoded by ORF5, the glycopro-present in virions, but are somehow disrupted when the
viral envelopes are treated with detergent. The associa- tein Gs encoded by ORF2, the M protein encoded by
ORF6, and the N protein encoded by ORF7. VP1/N en-tion of viral membrane proteins into homo- or hetero-
oligomers by means of noncovalent interactions is com- coded by ORF7, VP2/M encoded by ORF6, and the major
glycoprotein VP3 encoded by ORF5 were shown to bemonly observed (Doms et al., 1993). Interestingly, our
findings are in contrast with those for the Gs protein incorporated in virions of LDV (Harty and Plagemann,
1988, Faaberg et al., 1995). The next steps in LV researchencoded by ORF2 of EAV. The Gs protein was shown to
be a minor structural glycoprotein incorporated in virus must be to assess the function of the four structural
glycoproteins of LV in virus assembly, cell attachment,particles as a disulfide-linked dimer (de Vries et al., 1992
and 1995). Furthermore, four monomeric species gener- and infection.
ated by the formation of alternative intrachain disulfide
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